Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance resultsNorio Hanafusa, Michio Kato, Tomoaki Ishihara et al.|PLoS ONE|2017Cited by 56
A Road Map Toward Defining the Role of Smad Signaling in Hematopoietic Stem CellsTaiju Utsugisawa, Stefan Karlsson|Stem Cells|2005Cited by 45